Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

First published online June 7, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-0172v1
23/7/914    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sánchez-Pernaute, R.
Right arrow Articles by Isacson, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sánchez-Pernaute, R.
Right arrow Articles by Isacson, O.
Submitted on July 30, 2004
Accepted on March 21, 2005

Original Article

Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno1) after transplantation

Rosario Sánchez-Pernaute 1*, Lorenz Studer 2, Daniela Ferrari 3, Anselme Perrier 2, Hyojin Lee 2, Angel Viñuela 1, Ole Isacson 1

1 McLean Hospital/Harvard University Udall Parkinson's Disease Research Center of Excellence; Neuroregeneration Laboratories, McLean Hospital, 115 Mill St., Belmont, MA 02478
2 Laboratory of Stem Cell and Tumor Biology, Division of Neurosurgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 256, New York, NY 10021
3 Neuroregeneration Laboratories, McLean Hospital, 115 Mill St., Belmont, MA 02478; Stem Cell Research Institute, DIBIT, S. Raffaele Hospital, Via Olgettina 58, 20132 Milano

* To whom correspondence should be addressed. E-mail: rosario_pernaute{at}hms.harvard.edu.


  Abstract

Dopamine neurons can be derived from human and primate embryonic stem (ES) cells in vitro. An ES cell-based replacement therapy for patients with Parkinson's disease requires that in vitro generated neurons maintain their phenotype in vivo. Other critical issues relate to their proliferative capacity and risk of tumor formation, and the capability of migration and integration in the adult mammalian brain. Neural induction was achieved by co-culture of primate parthenogenetic ES cells (Cyno-1) with stromal cells followed by sequential exposure to midbrain patterning and differentiation factors to favor dopamine phenotypic specification. Differentiated ES cells were treated with mitomycin C and transplanted into adult immunosuppressed rodents and into a primate (allograft) without immunosuppression. A small percentage of dopamine neurons survived in both rodent and primate hosts for the entire term of the study (4 and 7 months, respectively). Other neuronal and glial populations derived from Cyno1 ES cells showed, in vivo, phenotypic characteristics, growth and migration patterns similar to fetal primate transplants and a majority of cells (>80%) expressed the forebrain transcription factor brain factor 1. No teratoma formation was observed. In this study we demonstrate long-term survival of dopamine neurons obtained in vitro from primate ES cells. Optimization of differentiation, cell selection and cell transfer is required for functional studies of ES-derived dopamine neurons for future therapeutic applications.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Aubry, A. Bugi, N. Lefort, F. Rousseau, M. Peschanski, and A. L. Perrier
Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats
PNAS, October 28, 2008; 105(43): 16707 - 16712.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
R. Sanchez-Pernaute, H. Lee, M. Patterson, C. Reske-Nielsen, T. Yoshizaki, K. C. Sonntag, L. Studer, and O. Isacson
Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease
Brain, August 1, 2008; 131(8): 2127 - 2139.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
F. Wianny, A. Bernat, C. Huissoud, G. Marcy, S. Markossian, V. Cortay, P. Giroud, V. Leviel, H. Kennedy, P. Savatier, et al.
Derivation and Cloning of a Novel Rhesus Embryonic Stem Cell Line Stably Expressing Tau-Green Fluorescent Protein
Stem Cells, June 1, 2008; 26(6): 1444 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
T. C. Dinger, S. Eckardt, S. W. Choi, G. Camarero, S. Kurosaka, V. Hornich, K. J. McLaughlin, and A. M. Muller
Androgenetic Embryonic Stem Cells Form Neural Progenitor Cells In Vivo and In Vitro
Stem Cells, June 1, 2008; 26(6): 1474 - 1483.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
D. Yang, Z.-J. Zhang, M. Oldenburg, M. Ayala, and S.-C. Zhang
Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats
Stem Cells, January 1, 2008; 26(1): 55 - 63.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
G. Brunlid, J. Pruszak, B. Holmes, O. Isacson, and K.-C. Sonntag
Immature and Neurally Differentiated Mouse Embryonic Stem Cells Do Not Express a Functional Fas/Fas Ligand System
Stem Cells, October 1, 2007; 25(10): 2551 - 2558.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
J. A. Rodriguez-Gomez, J.-Q. Lu, I. Velasco, S. Rivera, S. S. Zoghbi, J.-S. Liow, J. L. Musachio, F. T. Chin, H. Toyama, J. Seidel, et al.
Persistent Dopamine Functions of Neurons Derived from Embryonic Stem Cells in a Rodent Model of Parkinson Disease
Stem Cells, April 1, 2007; 25(4): 918 - 928.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
S. Eckardt, N. A. Leu, H. L. Bradley, H. Kato, K. D. Bunting, and K. J. McLaughlin
Hematopoietic reconstitution with androgenetic and gynogenetic stem cells
Genes & Dev., February 15, 2007; 21(4): 409 - 419.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S. Wang, X. Tang, Y. Niu, H. Chen, B. Li, T. Li, X. Zhang, Z. Hu, Q. Zhou, and W. Ji
Generation and Characterization of Rabbit Embryonic Stem Cells
Stem Cells, February 1, 2007; 25(2): 481 - 489.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
K.-C. Sonntag, J. Pruszak, T. Yoshizaki, J. van Arensbergen, R. Sanchez-Pernaute, and O. Isacson
Enhanced Yield of Neuroepithelial Precursors and Midbrain-Like Dopaminergic Neurons from Human Embryonic Stem Cells Using the Bone Morphogenic Protein Antagonist Noggin
Stem Cells, February 1, 2007; 25(2): 411 - 418.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
L. Lin and O. Isacson
Axonal Growth Regulation of Fetal and Embryonic Stem Cell-Derived Dopaminergic Neurons by Netrin-1 and Slits
Stem Cells, November 1, 2006; 24(11): 2504 - 2513.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. A. Lamba, M. O. Karl, C. B. Ware, and T. A. Reh
Efficient generation of retinal progenitor cells from human embryonic stem cells
PNAS, August 22, 2006; 103(34): 12769 - 12774.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
H. Shibata, N. Ageyama, Y. Tanaka, Y. Kishi, K. Sasaki, S. Nakamura, S.-i. Muramatsu, S. Hayashi, Y. Kitano, K. Terao, et al.
Improved Safety of Hematopoietic Transplantation with Monkey Embryonic Stem Cells in the Allogeneic Setting
Stem Cells, June 1, 2006; 24(6): 1450 - 1457.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2005 by AlphaMed Press.